Phase II https://www.bioworld.com/rss en-us Kardia-2 prods Alnylam’s zilebesiran forward, hypertension back http://www.bioworld.com/articles/706201 Tue, 05 Mar 2024 12:00:00 -0500 https://www.bioworld.com/articles/706201-kardia-2-prods-alnylams-zilebesiran-forward-hypertension-back Blood pressure cuff Stemcyte cleared to study umbilical cord blood stem cell therapy for post-COVID syndrome umbilical cord blood stem cell therapy for post-COVID syndrome, or long COVID.]]> http://www.bioworld.com/articles/522086 Tue, 30 Aug 2022 09:00:00 -0400 https://www.bioworld.com/articles/522086-stemcyte-cleared-to-study-umbilical-cord-blood-stem-cell-therapy-for-post-covid-syndrome Shock away? Adrenomed’s adrecizumab hits phase II endpoint in septic shock http://www.bioworld.com/articles/433224 Wed, 26 Feb 2020 11:00:00 -0500 https://www.bioworld.com/articles/433224-shock-away-adrenomeds-adrecizumab-hits-phase-ii-endpoint-in-septic-shock Neurotrope shares crushed on phase II bryostatin-1 fizzle in Alzheimer's http://www.bioworld.com/articles/429852 Tue, 10 Sep 2019 00:00:00 -0400 https://www.bioworld.com/articles/429852-neurotrope-shares-crushed-on-phase-ii-bryostatin-1-fizzle-in-alzheimers Aridis study failure ends development of AR-105 http://www.bioworld.com/articles/429259 Wed, 04 Sep 2019 00:00:00 -0400 https://www.bioworld.com/articles/429259-aridis-study-failure-ends-development-of-ar-105 Going all the way, NMDA work sped up as chances weighed for big players http://www.bioworld.com/articles/347404 Fri, 12 Jul 2019 00:00:00 -0400 https://www.bioworld.com/articles/347404-going-all-the-way-nmda-work-sped-up-as-chances-weighed-for-big-players Bionomics' BNC-210 fails in agitation, hope hangs on PTSD http://www.bioworld.com/articles/399430 Mon, 08 Jul 2019 00:00:00 -0400 https://www.bioworld.com/articles/399430-bionomics-bnc-210-fails-in-agitation-hope-hangs-on-ptsd Patient Experience Still Undervalued in Regulating Drugs http://www.bioworld.com/blogs/1/post/183 Mon, 28 Oct 2013 14:54:11 -0400 https://www.bioworld.com/blogs/1-bioworld-perspectives/post/183-patient-experience-still-undervalued-in-regulating-drugs World’s Oldest Clinical Trial . . . and Health Economics Not Far Behind http://www.bioworld.com/blogs/1/post/95 Fri, 04 Nov 2011 11:18:43 -0400 https://www.bioworld.com/blogs/1-bioworld-perspectives/post/95-world-s-oldest-clinical-trial-and-health-economics-not-far-behind- Race To Nowhere http://www.bioworld.com/blogs/1/post/30 Thu, 19 May 2011 14:42:02 -0400 https://www.bioworld.com/blogs/1-bioworld-perspectives/post/30-race-to-nowhere